Experimental & Molecular Medicine

Experimental & Molecular Medicine re-launches as open access

Experimental & Molecular Medicine (EMM) has re-launched on as a fully open-access title. Co-published by Nature Publishing Group (NPG) and the Korean Society for Biochemistry and Molecular Biology (KSBMB), EMM aims to publish the latest and most important advances in genetic, molecular and cellular studies of human physiology and diseases. 

'We are very excited to commence this new partnership with NPG,' said Dae-Myung Jue, editor-in-chief of EMM. 'We expect combining the publishing expertise of NPG with the fast-growing research in the field, especially in East Asia, will provide an ideal platform to address various medical problems that we face today.' 

'The formation of the partnership between NPG and the KSBMB means that EMM, Korea’s first biochemistry journal, is also the first Korean journal to join the NPG Asia-Pacific journals programme,' said Dugald McGlashan, publisher of NPG's Asia-Pacific Academic Journals.


As scholarly publishing edges closer to open access, industry players are devising radical ways to cut costs. Rebecca Pool reports


The need to organise information efficiently and reliably is more important than ever, argues Allan Gajadhar


The scholarly publishing community will descend on the ExCeL Centre for a two-day event in December, writes Clive Snell


Pinar Erzin is founder and president of Accucoms


 Suzanne Kavanagh, director of marketing and membership services at ALPSP, outlines what delegates can expect at their annual conference this September